These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23438882)

  • 21. Pharmacogenetics of osteoporosis-related bone fractures: moving towards the harmonization and validation of polymorphism diagnostic tools.
    Rojo Venegas K; Aguilera Gómez M; Eisman JA; García Sánchez A; Faus Dader MJ; Calleja Hernández MA
    Pharmacogenomics; 2010 Sep; 11(9):1287-303. PubMed ID: 20860468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics and pharmacogenomics of thienopyridines: clinically relevant?
    Close SL
    Fundam Clin Pharmacol; 2012 Feb; 26(1):19-26. PubMed ID: 21880067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical issues in genome-wide association studies for physical activity.
    Kim J; Oh S; Min H; Kim Y; Park T
    Ann N Y Acad Sci; 2011 Jul; 1229():38-44. PubMed ID: 21793837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The future of psychiatric pharmacogenomics.
    Lohoff FW
    Pharmacogenomics; 2011 Jul; 12(7):927-9. PubMed ID: 21787185
    [No Abstract]   [Full Text] [Related]  

  • 25. The pharmacogenetics of antipsychotic treatment.
    Reynolds GP
    Handb Exp Pharmacol; 2012; (212):213-39. PubMed ID: 23129334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of pharmacogenetics in clinical practice is challenging.
    van Schie RM; de Boer A; Maitland-van der Zee AH
    Pharmacogenomics; 2011 Sep; 12(9):1231-3. PubMed ID: 21919599
    [No Abstract]   [Full Text] [Related]  

  • 27. A new statistical screening approach for finding pharmacokinetics-related genes in genome-wide studies.
    Sato Y; Laird NM; Nagashima K; Kato R; Hamano T; Yafune A; Kaniwa N; Saito Y; Sugiyama E; Kim SR; Furuse J; Ishii H; Ueno H; Okusaka T; Saijo N; Sawada JI; Yoshida T
    Pharmacogenomics J; 2009 Apr; 9(2):137-46. PubMed ID: 19104505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomics of cardiovascular disease.
    Manace LC; Godiwala TN; Babyatsky MW
    Mt Sinai J Med; 2009 Dec; 76(6):613-23. PubMed ID: 20014425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.
    Umićević Mirkov M; Coenen MJ
    Pharmacogenomics; 2013 Mar; 14(4):425-44. PubMed ID: 23438889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How genetic variation affects patient response and outcome to therapy for psoriasis.
    Woolf RT; Smith CH
    Expert Rev Clin Immunol; 2010 Nov; 6(6):957-66. PubMed ID: 20979559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Race, ethnicity, ancestry, and pharmacogenetics.
    Urban TJ
    Mt Sinai J Med; 2010; 77(2):133-9. PubMed ID: 20309922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A commentary on implication of gene copy number variation in health and diseases.
    Kaname T
    J Hum Genet; 2012 Feb; 57(2):79-80. PubMed ID: 22158427
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacogenomics].
    Tsujimoto G
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):798-804. PubMed ID: 10771636
    [No Abstract]   [Full Text] [Related]  

  • 35. New approaches to personalized medicine for asthma: where are we?
    Weiss ST
    J Allergy Clin Immunol; 2012 Feb; 129(2):327-34. PubMed ID: 22284929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of single-nucleotide polymorphism maps in pharmacogenomics.
    McCarthy JJ; Hilfiker R
    Nat Biotechnol; 2000 May; 18(5):505-8. PubMed ID: 10802616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA pharmacogenomics: post-transcriptional regulation of drug response.
    Rukov JL; Shomron N
    Trends Mol Med; 2011 Aug; 17(8):412-23. PubMed ID: 21652264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pharmacogenomics primer.
    Court MH
    J Clin Pharmacol; 2007 Sep; 47(9):1087-103. PubMed ID: 17664254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacogenomics: hype or hope?].
    Schwab M; Schaeffeler E; Zanger UM; Brauch H; Kroemer HK
    Dtsch Med Wochenschr; 2011 Mar; 136(10):461-7. PubMed ID: 21365522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenomic discovery approaches: will the real genes please stand up?
    Walgren RA; Meucci MA; McLeod HL
    J Clin Oncol; 2005 Oct; 23(29):7342-9. PubMed ID: 16145062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.